Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

28.94

-1.06 (-3.53%)

At close: Mar 3, 2026, 4:00 PM EST

28.94

0.00 (0.00%)

After-hours: Mar 3, 2026, 5:03 PM EST

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,926	1,805	1,677	2,169	2,099	1,803
Market Cap Growth	27.92%	7.65%	-22.71%	3.32%	16.42%	160.10%
Enterprise Value	1,410	1,224	924	1,936	1,779	1,383
Last Close Price	28.94	27.16	25.27	39.66	44.57	38.64
PS Ratio	1246.88	1168.13	238.82	315.12	890.64	387.68
PB Ratio	3.65	3.42	2.24	5.05	6.44	4.30
P/TBV Ratio	3.85	3.61	2.33	5.40	7.02	4.60
EV/Sales Ratio	912.75	792.34	131.57	281.34	754.94	297.37
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.98	-0.98	-0.97	-0.98	-0.92	-0.97
Net Debt / EBITDA Ratio	1.82	1.82	3.76	3.03	2.89	6.13
Net Debt / FCF Ratio	2.42	2.42	4.52	3.86	2.85	6.52
Asset Turnover	0.00	0.00	0.01	0.02	0.01	0.01
Quick Ratio	10.21	10.21	18.38	13.69	16.41	24.71
Current Ratio	10.49	10.49	18.92	13.87	17.07	24.86
Return on Equity (ROE)	-40.62%	-40.62%	-26.84%	-37.45%	-30.13%	-22.43%
Return on Assets (ROA)	-26.12%	-26.12%	-19.38%	-21.70%	-16.79%	-12.70%
Return on Capital Employed (ROCE)	-54.00%	-54.00%	-25.90%	-32.70%	-32.10%	-16.20%
Earnings Yield	-13.43%	-14.34%	-9.42%	-6.52%	-5.35%	-3.91%
FCF Yield	-11.09%	-11.84%	-9.53%	-5.03%	-5.03%	-3.45%
Buyback Yield / Dilution	-3.15%	-3.15%	-32.91%	-3.33%	-9.37%	-44.64%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q